PlainRecalls
FDA Drug Moderate Class II Terminated

Atropine Sulfate PF INJ, 0.8 mg/2 mL (0.4 mg/mL), 2mL Single Dose Syringe, Rx only, Premier Pharmacy Labs, 8265 Commercial Way, Weeki Wachee, FL 34613, NDC: 69623-131-12, barcode 0 69623 13112 6.

Reported: July 3, 2019 Initiated: June 18, 2019 #D-1411-2019

Product Description

Atropine Sulfate PF INJ, 0.8 mg/2 mL (0.4 mg/mL), 2mL Single Dose Syringe, Rx only, Premier Pharmacy Labs, 8265 Commercial Way, Weeki Wachee, FL 34613, NDC: 69623-131-12, barcode 0 69623 13112 6.

Reason for Recall

Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.

Details

Recalling Firm
Premier Pharmacy Labs Inc
Units Affected
745 syringes
Distribution
Nationwide in the USA
Location
Weeki Wachee, FL

Frequently Asked Questions

What product was recalled?
Atropine Sulfate PF INJ, 0.8 mg/2 mL (0.4 mg/mL), 2mL Single Dose Syringe, Rx only, Premier Pharmacy Labs, 8265 Commercial Way, Weeki Wachee, FL 34613, NDC: 69623-131-12, barcode 0 69623 13112 6.. Recalled by Premier Pharmacy Labs Inc. Units affected: 745 syringes.
Why was this product recalled?
Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 3, 2019. Severity: Moderate. Recall number: D-1411-2019.